Cargando…
Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor
Autores principales: | Grohs, Laura, Cheng, Linhan, Cönen, Saskia, Haddad, Bassam G., Bülow, Astrid, Toklucu, Idil, Ernst, Lisa, Körner, Jannis, Schmalzing, Günther, Lampert, Angelika, Machtens, Jan-Philipp, Hausmann, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10274573/ https://www.ncbi.nlm.nih.gov/pubmed/37332347 http://dx.doi.org/10.3389/fphar.2023.1225522 |
Ejemplares similares
-
Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor
por: Grohs, Laura, et al.
Publicado: (2023) -
Uncoupling sodium channel dimers restores the phenotype of a pain‐linked Na(v)1.7 channel mutation
por: Rühlmann, Annika H., et al.
Publicado: (2020) -
Functional subgroups of rat and human sensory neurons: a systematic review of electrophysiological properties
por: Körner, Jannis, et al.
Publicado: (2022) -
Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology
por: Altman, Roy, et al.
Publicado: (2015) -
NSAIDs Ibuprofen, Indometacin, and Diclofenac do not interact with Farnesoid X Receptor
por: Schmidt, Jurema, et al.
Publicado: (2015)